Pathogenic or likely pathogenic variants in the DEPDC5, NPRL2 and NPRL3 genes were identified in 8–11% of individuals within focal epilepsy cohorts, mostly comprised of familial non-lesional cases.3 This evidence concerns the gene NPRL2 and focal epilepsy.